GRPR

You have access
MITIGATE-NeoBOMB1, a Phase I/IIa Study to Evaluate Safety, Pharmacokinetics, and Preliminary Imaging of ⁶⁸Ga-NeoBOMB1, a Gastrin-Releasing Peptide Receptor Antagonist, in GIST Patients
Leonhard Gruber, Luis David Jiménez-Franco, Clemens Decristoforo, Christian Uprimny, Gerhard Glatting, Peter Hohenberger, Stefan O. Schoenberg, Wolfgang Reindl, Francesca Orlandi, Maurizio Mariani, Werner Jaschke and Irene Virgolini

Journal of Nuclear Medicine December 1, 2020, 61 (12) 1749-1755; DOI: https://doi.org/10.2967/jnumed.119.238808
You have access
Imaging the Distribution of Gastrin-Releasing Peptide Receptors in Cancer
Lucia Baratto, Heying Duan, Helmut Mäcke and Andrei Iagaru

Journal of Nuclear Medicine June 1, 2020, 61 (6) 792-798; DOI: https://doi.org/10.2967/jnumed.119.234971
You have access
Expression of Gastrin-Releasing Peptide Receptor in Breast Cancer and Its Association with Pathologic, Biologic, and Clinical Parameters: A Study of 1,432 Primary Tumors
Clément Morgat, Gaétan MacGrogan, Véronique Brouste, Valérie Vélasco, Nicolas Sévenet, Hervé Bonnefoi, Philippe Fernandez, Marc Debled and Elif Hindié

Journal of Nuclear Medicine September 1, 2017, 58 (9) 1401-1407; DOI: https://doi.org/10.2967/jnumed.116.188011
You have access
Clinical Translation of a Dual Integrin α_vβ₃– and Gastrin-Releasing Peptide Receptor–Targeting PET Radiotracer, ⁶⁸Ga-BBN-RGD
Jingjing Zhang, Gang Niu, Lixin Lang, Fang Li, Xinrong Fan, Xuefeng Yan, Shaobo Yao, Weigang Yan, Li Huo, Libo Chen, Zhiyuan Li, Zhaohui Zhu and Xiaoyuan Chen

Journal of Nuclear Medicine February 1, 2017, 58 (2) 228-234; DOI: https://doi.org/10.2967/jnumed.116.177048
You have access
^99mTc-Glu-c(RGDyK)-Bombesin SPECT Can Reduce Unnecessary Biopsy of Masses That Are BI-RADS Category 4 on Ultrasonography
Tiefeng Ji, Shi Gao, Zhaofei Liu, Hua Xing, Guoqing Zhao and Qingjie Ma

Journal of Nuclear Medicine August 1, 2016, 57 (8) 1196-1200; DOI: https://doi.org/10.2967/jnumed.115.168773
You have access
Clinical Relevance of Targeting the Gastrin-Releasing Peptide Receptor, Somatostatin Receptor 2, or Chemokine C-X-C Motif Receptor 4 in Breast Cancer for Imaging and Therapy
Simone U. Dalm, Anieta M. Sieuwerts, Maxime P. Look, Marleen Melis, Carolien H.M. van Deurzen, John A. Foekens, Marion de Jong and John W.M. Martens

Journal of Nuclear Medicine October 1, 2015, 56 (10) 1487-1493; DOI: https://doi.org/10.2967/jnumed.115.160739
You have access
In Vivo Cancer Dual-Targeting and Dual-Modality Imaging with Functionalized Quantum Dots
Kongzhen Hu, Hongliang Wang, Ganghua Tang, Tingting Huang, Xiaolan Tang, Xiang Liang, Shaobo Yao and Dahong Nie

Journal of Nuclear Medicine August 1, 2015, 56 (8) 1278-1284; DOI: https://doi.org/10.2967/jnumed.115.158873
You have access
Preclinical Comparison of Al¹⁸F- and ⁶⁸Ga-Labeled Gastrin-Releasing Peptide Receptor Antagonists for PET Imaging of Prostate Cancer
Kristell L.S. Chatalic, Gerben M. Franssen, Wytske M. van Weerden, William J. McBride, Peter Laverman, Erik de Blois, Bouchra Hajjaj, Luc Brunel, David M. Goldenberg, Jean-Alain Fehrentz, Jean Martinez, Otto C. Boerman and Marion de Jong

Journal of Nuclear Medicine December 1, 2014, 55 (12) 2050-2056; DOI: https://doi.org/10.2967/jnumed.114.141143
You have access
A Comparative Study of Radiolabeled Bombesin Analogs for the PET Imaging of Prostate Cancer
Yang Liu, Xiang Hu, Hongguang Liu, Lihong Bu, Xiaowei Ma, Kai Cheng, Jinbo Li, Mei Tian, Hong Zhang and Zhen Cheng

Journal of Nuclear Medicine December 1, 2013, 54 (12) 2132-2138; DOI: https://doi.org/10.2967/jnumed.113.121533

Main menu

User menu

Search

GRPR